Microsoft has partnered with Adaptive Biotechnologies to map the genetics of the human immune system, or immunome, in order to detect cancers and other diseases in their earliest stage, when they can be more effectively treated. This announcement came a week ago through a press release.
The two companies are combining their expertise to proffer solution to man’s most killer diseases. The partnership is aimed at creating individual disease diagnostics from a blood test, which would ultimately become a universal diagnostic tool. Microsoft will be providing its research and large-scale machine learning and cloud computing capabilities while Adaptive Biotech will be bringing its powerful immune sequencing technologies to the table.
Chad Robins, President, CEO and Co-Founder of Adaptive Biotechnologies had said during the announcement that the partnership is coming “at a time of inflection in healthcare and biotechnology. We now have the technology to be able to do what we’ve been talking about for the past decade – develop a universal TCR antigen map that presents an opportunity to help patients at an unprecedented scale”. He further said “Some conditions like cancer or autoimmune disorders can be difficult to diagnose, but this universal map of the immune system will enable earlier and more accurate diagnosis of disease, potentially helping physicians to connect the dots to understand the relationship between disease states and eventually lead to a better understanding of overall human health.”
This collaboration is a cornerstone of Microsoft’s Healthcare NExT initiative, and a first partnership between a leading genomics and technology company to map the genetics of the immune system. The Microsoft Healthcare NExT initiative was launched last year to maximize the ability of artificial intelligence and cloud computing to accelerate innovation in the healthcare industry, advance science through technology, and turn the lifesaving potential of next discoveries into reality.
In a statement issued by Microsoft, reads in part, “we’re incredibly excited to collaborate on this project with our partners at Adaptive, who have developed unique immunosequencing capabilities and immune system knowledge, along with very large data sets of TCR sequences. Classifying and mapping this data represents a large-scale machine learning project for which we’ll lean heavily on Microsoft’s cloud computing capabilities and our elite research teams”.
Microsoft was founded by Paul Allen and Bill Gates on April 4, 1975. The American multinational technology company develops, manufactures, licenses, supports and sells computer software, consumer electronics and personal computers and services.